Dube Eric M
SEC insider (Form 3/4/5 filer). CIK 0001763494. CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX). 47 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in SAN DIEGO, CA.
Companies Dube Eric M has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Director, Officer, CHIEF EXECUTIVE OFFICER
Dube Eric M
CIK: 0001763494
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (47 total)
- Oct 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect37.3K shares at avg. $54.20$2.0M - Oct 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect43.7K shares at avg. $26.88$1.2M - Oct 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect78.4K shares at avg. $55.02$4.3M - Oct 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect200K shares at avg. $8.93$1.8M - Oct 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect128.1K shares at avg. $52.97$6.8M - Sep 17, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect108.5K shares at avg. $23.34$2.5M - Sep 17, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect6.8K shares at avg. $64.95$442K - Sep 17, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect101.7K shares at avg. $64.59$6.6M - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect99.7K shares at avg. $63.26$6.3M - Sep 16, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect195.8K shares at avg. $23.34$4.6M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 37,270 | $54.20 | $2,020,023 | Direct |
| Oct 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 43,735 | $26.88 | $1,175,597 | Direct |
| Oct 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 78,400 | $55.02 | $4,313,403 | Direct |
| Oct 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 200,000 | $8.93 | $1,786,000 | Direct |
| Oct 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 128,065 | $52.97 | $6,783,244 | Direct |
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 108,493 | $23.34 | $2,532,227 | Direct |
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 6,802 | $64.95 | $441,795 | Direct |
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 101,691 | $64.59 | $6,567,876 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 99,716 | $63.26 | $6,307,964 | Direct |
| Sep 16, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 195,841 | $23.34 | $4,570,929 | Direct |
1-10 of 47 transactions